Rapid test-based COVID diagnosis, prescription to apply nationwide: CECC

Rapid test-based COVID-19 diagnoses will soon be available nationwide instead of only to specific groups starting later this week so that people with COVID-19 can get easier access to oral antiviral medicines, the Central Epidemic Command Center (CECC) said Sunday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)